Compare VERX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERX | ITGR |
|---|---|---|
| Founded | 1978 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 3.0B |
| IPO Year | 2020 | 2000 |
| Metric | VERX | ITGR |
|---|---|---|
| Price | $12.83 | $86.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $28.29 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.9M | 835.8K |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | $748,444,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $12.78 | $1.69 |
| Revenue Next Year | $11.61 | $6.53 |
| P/E Ratio | $302.25 | ★ $29.97 |
| Revenue Growth | ★ 12.25 | 7.98 |
| 52 Week Low | $11.87 | $62.00 |
| 52 Week High | $42.44 | $127.56 |
| Indicator | VERX | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 52.21 |
| Support Level | $11.91 | $82.78 |
| Resistance Level | $15.80 | $87.54 |
| Average True Range (ATR) | 0.62 | 2.71 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 1.00 | 46.99 |
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.